Healthpeak Properties (NYSE:DOC – Get Free Report) had its target price decreased by stock analysts at Robert W. Baird from $24.00 to $22.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s price objective points to a potential upside of 23.18% from the stock’s previous close.
DOC has been the subject of a number of other research reports. Wedbush decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, April 23rd. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. Scotiabank lowered their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Finally, Evercore ISI cut their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $23.42.
Get Our Latest Report on Healthpeak Properties
Healthpeak Properties Stock Up 0.6 %
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 earnings per share. As a group, analysts expect that Healthpeak Properties will post 1.86 EPS for the current fiscal year.
Insider Activity
In other news, Director John T. Thomas bought 4,200 shares of the business’s stock in a transaction dated Monday, April 28th. The stock was purchased at an average cost of $17.84 per share, with a total value of $74,928.00. Following the acquisition, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Scott M. Brinker bought 11,337 shares of the firm’s stock in a transaction that occurred on Monday, April 28th. The stock was purchased at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now owns 201,863 shares in the company, valued at approximately $3,568,937.84. This trade represents a 5.95 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.23% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in DOC. Mizuho Bank Ltd. purchased a new stake in shares of Healthpeak Properties during the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd acquired a new position in Healthpeak Properties in the 4th quarter worth about $30,000. Future Financial Wealth Managment LLC acquired a new position in Healthpeak Properties in the 1st quarter worth about $30,000. S.A. Mason LLC boosted its position in Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 925 shares in the last quarter. Finally, Covestor Ltd grew its holdings in Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,152 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Conference Calls and Individual Investors
- Why D-Wave’s Project With Davidson Is a Game-Changer For Quantum
- What is Put Option Volume?
- Hims & Hers Stock Soars on Novo Nordisk Collaboration
- Learn Technical Analysis Skills to Master the Stock Market
- Amazon’s Earnings Will Make or Break the Stock’s Comeback
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.